
Sign up to save your podcasts
Or


Summary
In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.
By Colabra4.8
273273 ratings
Summary
In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.

31,965 Listeners

4,265 Listeners

2,455 Listeners

763 Listeners

1,354 Listeners

517 Listeners

823 Listeners

6,412 Listeners

125 Listeners

322 Listeners

4,175 Listeners

27 Listeners

5,573 Listeners

34 Listeners

19 Listeners